Innovative Industrial Properties amended its existing at-the-market (ATM) offering program to add its 9.25% Series B Cumulative Redeemable Preferred Stock to the facility. The program allows for the sale of common and preferred shares with an aggregate offering price of up to $500 million, of which approximately $336.9 million remains available for future issuance.
Innovative Industrial Properties filed Articles Supplementary to increase the number of authorized shares of its 9.25% Series B Cumulative Redeemable Preferred Stock by 16.1 million shares. This brings the total authorized and classified Series B Preferred Stock to 18.4 million shares. The filing notes that as of the date of the report, no shares have been issued or sold under this new authorization.
Innovative Industrial Properties reported net income attributable to common stockholders of $99.5 million for the nine months ended September 30, 2026, an increase from $83.7 million in the prior year period. The company significantly expanded its life science investments to $417.4 million and issued $402.5 million in exchangeable notes to manage its capital structure.
IIPR is aggressively diversifying into life sciences to offset cannabis tenant defaults, leveraging a strong balance sheet and new preferred stock capital.
Innovative Industrial Properties reported Q3 2026 total revenues of $64.9 million and AFFO of $1.96 per share, representing a 7% increase over the prior quarter. The company highlighted significant investment activity, including a $245 million mezzanine loan commitment for a life science campus in Cambridge, Massachusetts, and $30 million in preferred equity funding for IQHQ, Inc.
Term
Q3 2026
“We are pleased to report strong earnings with our AFFO per share up 7% compared to the second quarter, and are encouraged by the continued leasing momentum across our portfolio, reflecting our team's ongoing efforts to re-lease properties.”
Innovative Industrial Properties $62.5M Debt Financing with East West Bank
Innovative Industrial Properties, through its operating partnership, entered into a sixth amendment to its secured revolving credit facility with East West Bank. The amendment extends the maturity date of the facility from October 23, 2026, to January 21, 2027, with $62.5 million in aggregate principal currently outstanding.